Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TargetEveryone’s associated company in Norway, Cloud Explorers, signs new contract with PostNord

TargetEveryone’s associated company in Norway, Cloud Explorers, signs a new contract with PostNord as a customer. PostNord offers communications and logistics solutions to, from and within the Nordic region. In 2018, PostNord delivered 3.3 billion letters and shipments, 171 million parcels to the Nordic region’s 27 million residents and two million businesses. PostNord is owned 40% by the Danish State and 60% by the Swedish State.   TargetEveryone has an ownership of 30 % in Cloud Explorers and is also the exclusive tech partner to TargetEveryone in the development of SpectrumOne.

Carbiotix signs collaboration agreement with academic partner focused on neuroinflammation

Carbiotix (publ) ("Carbiotix") announces today that the company has signed a collaboration agreement with the Department of Medicine at the University of Verona, Italy, to carry out a research study during H1 2020 in the area of neuroinflammation using Carbiotix Microbiome Modulator Therapeutics. The collaboration agreement will seek to find new applications and further validate Carbiotix platform.The in-vivo research study to be conducted in H1 2020 will be led by Dr. Elena Zenaro, a researcher at the Department of Medicine, General Pathology Section, at the University of Verona, Italy.

Scandion Oncology obtains approval from the Ethics Committee on Clinical Application for SCO-101 in patients with drug-resistant metastatic colorectal cancer

Scandion Oncology A/S ("Scandion Oncology") today announces that the company has received approval from the Ethics Committee regarding its first clinical trial for SCO-101 at hospitals in Denmark. The only change that the Ethics Committee requested was to include a one-page summary of the patient information sheet for review before the study could be started.  With this approval, Scandion Oncology follows its objectives.Clinical Phase II trial with SCO-101 in patients with drug-resistant metastatic colorectal cancer Scandion Oncology’s first clinical Phase II study with SCO-101 targeting

Information about the AGM and appointed Nomination Committee in K-Fast Holding AB

The Annual General Meeting (“AGM”) in K-Fast Holding AB will be held on Tuesday 19 May 2020, at 5 p.m. CET. Venue: Hotel Statt, Frykholmsgatan 13 in Hässleholm, Sweden.Shareholders who wish to have a matter dealt with at the AGM shall, in order for the request to be taken into consideration, submit such proposal to the Board latest by 31 March 2020. The Board can be contacted through the Secretary of the Board at e-mail: ck@vici.se or by regular mail: K-Fastigheter, Nomination Committee, Bultvägen 7, SE-281 42, Hässleholm, Sweden. According to the instructions for the Nomination

Karolinska University Hospital part of the first kidney transplant program across Scandinavia – Scandia Transplant Kidney Exchange Program (STEP)

For the first time two kidney replacements have been performed involving donors and transplant patients who are part of the Scandinavian kidney exchange program STEP organized by Scandiatransplant.  The organization coordinates organ donations and transplants in Denmark, Estonia, Finland, Iceland, Norway and Sweden. During 2018 and 2019 Karolinska University Hospital performed and coordinated three STEP exchange programs with a total of six couples in cooperation with other hospitals in Sweden.- The number of patients waiting for a new kidney in Sweden increased by more than 10% from 2018

TietoEVRY: Holding of Apax Guernsey (Holdco) PCC Limited below 20%

TietoEVRY Corporation STOCK EXCHANGE RELEASE 23 December 2019 9.30 am EETTietoEVRY: Holding of Apax Guernsey (Holdco) PCC Limited below 20% TietoEVRY Corporation has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Apax Guernsey (Holdco) PCC Limited. The holding of Apax Guernsey (Holdco) PCC Limited has fallen below the 20% threshold on 20 December. The holding of Lyngen Holdco S.à r.l., a company ultimately controlled by Apax Guernsey (Holdco) PCC Limited, amounts to 19 872 767 shares, representing 16.78% of the shares and

SpareBank 1 SR-Bank ASA (SRBANK); CORRECTION - Decision of MREL requirement has been made public

SpareBank 1 SR-Bank ASA has received its MREL requirement from the Norwegian Financial Supervisory Authority. According to the notice, SpareBank SR-Bank shall hold total MREL capital equal to 32.9 per cent of adjusted Risk Weighted Assets. The requirement is based on the bank’s balance as of 31 December 2018. This leads to a requirement of eligible liabilities of NOK 33 714 million. The MREL requirement, according to the notice, is applicable from 31 March 2020. The requirement for eligible liabilities is applicable from 31 December 2022. Senior preferred debt, with remaining maturity

Board members and management in Initiator Pharma exercise warrants

Initiator Pharma A/S (INIT) today announces that individuals in the board and managemet exercise a total of 434 197 warrants for subscription of new shares, raising approx 1,9 SEKM in proceeds to the company. The number of issued shares increases by 434 197 and the share capital increases by 45 590,685 DKK.The warrants have been exercised under the warrant program 2017/2020, approved by the Annual General Meeting of 16 May 2017, comprising 434,197 warrants and has been fully exercised according to the below distribution: [][][][]Individual[1] Position Excercised Share holding

MREL requirement

Further to today’s announcement from the Norwegian Financial Supervisory Authority (the “FSA”), DNB ASA has received minimum requirement for own funds and eligible liabilities (the “MREL requirement”). DNB ASA shall hold total MREL capital equal to 36.7 percent of its adjusted risk weighted assets based on the balance per 31 December 2018, which leads to a need for eligible debt of NOK 157 billion. This is in line with the previously communicated expectation of approximately NOK 150 billion. The MREL requirement will vary over time based on changes in risk weighted assets and capital

Axel Johnson International extends its offering in power transmission solutions in Slovenia

Axel Johnson International’s business group Power Transmission Solutions has acquired Bell d.o.o., effective 19 December 2019. Bell is a leading Slovenian provider of power transmission products and services since more than 30 years.“Entering the Slovenian market by the acquisition of Bell is well in line with our business group strategy for expanded geographical presence and further strengthened market offering in services and technical expertise. The Slovenian market offers many structural advantages for the power transmission industry, which caters for good long-term growth prospects”,

The pivotal Phase 3 clinical trial NefIgArd Part A fully recruited

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced the full recruitment of all 200 patients required for Part A of the company’s pivotal Phase 3 study NefIgArd. Top line readout of Part A of the study is expected in Q4 2020.The study will continue to recruit an additional 160 patients during 2020 in order to complete Part B of the trial. The NefIgArd trial is studying the effect of Nefecon versus placebo on proteinuria in patients with IgA nephropathy (IgAN) at approximately 140 sites in 19 countries.  The first patient was randomized in November 2018. On the basis of

Enhertu (trastuzumab deruxtecan) approved in US

23 December 2019 07:00 GMT Enhertu (trastuzumab deruxtecan) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prioranti-HER2 based regimens Accelerated Approval of AstraZeneca and Daiichi Sankyo's Enhertu based on the DESTINY-Breast01 trial that showed clinically meaningful and durable responses AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced that the US Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of adult patients with unresectable or

Triple-combination approved in China for COPD

23 December 2019 07:00 GMT AstraZeneca's triple-combination therapyapproved in China for patients with COPD First fixed-dose triple-combination therapy in apressurised metered-dose inhaler device in China Budesonide/glycopyrronium/formoterol fumarate is known asPT010 outside of China and as Breztri Aerosphere in Japan AstraZeneca today announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This is the first approval by the National Medical Products

Catena Media agrees on amended and final terms for US assets acquired in December 2016

Catena Media plc (Nasdaq Stockholm: CTM). Catena Media has agreed with the sellers of U.S. assets acquired in December 2016 to amend the final earn-out terms. The final earn-out payment corresponds to a total of USD 19,386,876, 30% of which will be paid in cash in April 2020, and 70% of which will be paid through a share issue, to be made to the sellers as soon as possible in 2020.In December 2016, Catena Media acquired assets in the regulated online casino and poker markets in the U.S. states New Jersey and Nevada. In October 2018, Catena Media agreed with the sellers on the structure of

Let’s celebrate New Year with Amazing Thailand Countdown 2020 wherever you are in Thailand!

Tourism Authority of Thailand inviting you to celebrate Year 2020 with events around Thailand.‘Amazing Thailand Countdown 2020’, one of the biggest events TAT stages in various destinations across the country, to bid farewell to 2019 and welcome 2020 with Thai style and panache. Highlights in the six emerging destinations include: Amazing Night Sukhothai Countdown 2020 (29-31 December 2019) at Sukhothai Historical Park Three days of ‘light up the night’ decorations in combination with contemporary music performances and classical Thai dances. Watch the last sunset of the

Metacon Moves Headquarters to Örebro

Metacon today announced that it has selected Örebro for its corporate headquarters location.“Metacon aspires to become a leading provider of technology and solutions for local production of hydrogen out of natural gas, biogas and other hydrocarbons” said CEO Chris Tornblom. "Örebro is home to a high-ranking university internationally, known for its high quality research. Örebro attracts a diverse workforce and offers cutting edge manufacturing as well as great logistics infrastructure. We are excited to bring our headquarters to this growing and creative city.” The new offices comes with

SpareBank 1 SR-Bank ASA (SRBANK); Decision of MREL requirement has been made public

SpareBank 1 SR-Bank ASA has received an advance notice of its MREL requirement from the Norwegian Financial Supervisory Authority. According to the notice, SpareBank SR-Bank shall hold total MREL capital equal to 32.9 per cent of adjusted Risk Weighted Assets. The requirement is based on the bank’s balance as of 31 December 2018. This leads to a requirement of eligible liabilities of NOK 33 714 million. The MREL requirement, according to the notice, is applicable from 31 March 2020. The requirement for eligible liabilities is applicable from 31 December 2022. Senior preferred debt, with

SpareBank 1 Nord-Norge has received its Minimum Requirement for Own Funds and Eligible Liabilities (MREL)

SpareBank 1 Nord-Norge has received its MREL requirement from the Norwegian Financial Supervisory Authority. According to the notice, SpareBank 1 Nord-Norge shall hold total MREL capital equal to 32.5 per cent of adjusted Risk Weighted Assets (RWA). The requirement is based on the group’s balance as of 31 December 2018, and adjusting for the group’s level of own funds, this leads to a requirement of eligible liabilities of NOK 8 108 million. The MREL requirement, according to the notice, is applicable from 31 March 2020. The requirement for eligible liabilities is applicable from 31

Loudspring Oyj - Manager’s Transactions

Loudspring Oyj Company Release 23 December 2019 at 08.30 (EET)   Person subject to the notification requirement Name: Joki-Tokola, Jarkko Position: Managing Director Issuer: Loudspring Oyj LEI: 74370040F0RYWDWUJC65 Notification type: Initial notification Reference number: 74370040F0RYWDWUJC65_20191220143400_4 Transaction date: 2019-12-18 Venue: OFF-EXCHANGE TRANSACTIONS (XOFF) Instrument type: Share ISIN: FI4000092523 Nature of the transaction: SUBSCRIPTION Transaction Details (1): Volume: 500 000 Unit price: 0.30 EUR Aggregated

Share buy-backs in Telia Company during week 51 2019

During the period December 16, 2019 until December 20, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,815,398 own shares (ISIN: SE0000667925).The share buy-backs form part of the SEK 5 billion share buy-back program that Telia Company announced on April 16, 2019. The share buy-back program, which runs between April 16, 2019 and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

Skanska divests the office building 99M in Washington, DC, USA, for USD 163 M, about SEK 1.5 billion

Skanska divests the office building 99M in Washington, DC, USA, for USD 163 M, about SEK 1.5 billion, to an affiliate of Polinger Development Co. The transaction will be recorded by Skanska USA Commercial Development in the fourth quarter 2019. The transfer of the property is expected to occur in the first quarter 2020.99M is an 11-story, 21,700 square-meter (234,000-square-foot), LEED Gold certified office building in Washington D.C. It is 87 percent leased. Office tenants include Common Grounds, Pyxera Global and Give Campus. In addition to ground floor retail the building offers

SBB has entered into agreements for the sale of 46 properties for an agreed property value exceeding SEK 1bn

Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") has entered into agreements for the sale of 46 properties, mainly within office, LSS and HVB segments, located foremost in the mid- and southern part of Sweden. The sale is carried out to an agreed property value exceeding SEK 1bn which exceeds the book value with approximately 10 per cent. "The asset sale shows once again that SBB’s property portfolio, including non-core assets with strong cash-flows, is highly liquid and attractive,” comments Ilija Batljan, CEO and Founder of SBB.

Magnolia Bostad has during the fourth quarter started production of a total of four projects and 1,350 residential units

The production starts refers to two projects in the existing project portfolio located in Lund and Spånga as well as two newly acquired projects located in Norrköping and Ystad for a total of around 1,350 residential units, of which 80 are residential care units. All projects will be certified with the Sweden Green Building Council’s Silver certificate and the projects in Ystad and Norrköping will be built in wood.The project in Spånga has, according to a press release on December 23, 2019 at 06.45, been sold to Heimstaden Bostad. For the project in Lund, a turnkey contract for

There are no items matching the current filter
There are no more items matching the current filter
Back to top